BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221003
DTEND;VALUE=DATE:20221006
DTSTAMP:20260516T035240
CREATED:20220623T103213Z
LAST-MODIFIED:20220623T103213Z
UID:34498-1664755200-1665014399@www.pharmajournalist.com
SUMMARY:LEAP TA: Life Sciences 2022
DESCRIPTION:The Definitive Event to Transform Your Internal Impact & Differentiate Your Employer Brand to Attract the in-Demand Biopharma Talent Required to Fast-Track Business Innovation & Growth \nNow in its fourth year\, LEAP TA: Life Sciences is the only forum dedicated to helping established and emerging life sciences organizations operating in the US who are breaking away from traditional TA to develop high functioning TA teams bursting to inspire talent needed to drive mission-critical innovation. \nIt is a unique opportunity to engage in a genuinely disruptive dialogue with your peers around what TA tech tools are really worth the investment and the radical new talent acquisition strategies required to address how life sciences organizations will deal with the fallout of the tight talent market in 2022 and beyond. \nDesigned for anyone with a stake in talent acquisition at the heart of biopharma businesses of all sizes\, those who take part will find out how to rewrite the rules of talent acquisition to balance speed with fit in finding brilliant people to gain a sustainable competitive advantage. \nSo\, whether you work in the newest start-up biotech or the largest big pharma company\, there’s something at this event for you. Secure your place now to save time\, money and add vital efficiencies to your talent acquisition activities. \nTo know more visit: https://bit.ly/3HO1Tdv
URL:https://www.pharmajournalist.com/event/leap-ta-life-sciences-2022/
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207 Porter St\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221007
DTSTAMP:20260516T035240
CREATED:20220610T091530Z
LAST-MODIFIED:20220610T091530Z
UID:34394-1664841600-1665100799@www.pharmajournalist.com
SUMMARY:2nd Rare and Genetic Kidney Drug Development Summit
DESCRIPTION:Uniting industry experts dedicated to accelerating the frontier of transformative therapeutics\, the 2nd Rare & Genetic Kidney Disease Drug Development Summit is the definitive industry forum sharing cross-industry insight to understand genetic drivers of disease\, uncover early biomarkers of efficacy\, and navigate disease specific endpoint development. \nFrom clarifying molecular characteristics to reclassify disease subtypes to enrolling patient cohorts in rare disease populations\, join industry experts in-person from Travere Therapeutics\, FDA\, Sanofi\, Chinook Therapeutics\, Goldfinch Bio\, Takeda\, Regulus Therapeutics\, Otsuka and many more to accelerate life-changing therapeutics for the treatment of ADPKD\, ARPKD\, IgA\, FSGS\, Alport Syndrome. \nTo know more visit: https://ter.li/rzowfh
URL:https://www.pharmajournalist.com/event/2nd-rare-and-genetic-kidney-drug-development-summit/
LOCATION:Hilton Woburn\, 2 Forbes Road\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:(+1) 617 455 4188
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221007
DTSTAMP:20260516T035240
CREATED:20220630T094848Z
LAST-MODIFIED:20220630T094848Z
UID:34555-1664841600-1665100799@www.pharmajournalist.com
SUMMARY:4th Macrophage-directed Therapies Summit
DESCRIPTION:4th Macrophage-directed Therapies Summit\, taking place from 4-6 of October in Boston\, will bring together professionals to accelerate the clinical validation of macrophage-directed therapies\, manipulating and fixing phenotypic plasticity to develop safe\, targeted therapies for oncology\, autoimmunity\, inflammation and beyond. \nJoin your peers in person and delve into: \n\nCD47 targeting and other ‘don’t eat me’ signals\nSafety concerns due to model translatability and dosing\nOptimal combination or monotherapy discovery\n\nYou can view the event guide here: https://ter.li/ezyi0h \nSecure your place at the summit here: https://ter.li/x9p0ua \nWe are looking forward to welcoming you to Boston this October!
URL:https://www.pharmajournalist.com/event/4th-macrophage-directed-therapies-summit/
LOCATION:Crowne Plaza Boston Woburn\, 15 Middlesex Canal Park Dr\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR